Is CORBUS undervalued?
At only 450mcap is Corbus Pharmaceuticals undervalued?
1) Corbus is different from other cannabis stocks as they are designing therapies around marijuana to treat fibrotic diseases. If these therapies work, some analysts put the value of their potential sales at
2BN a year.
2) At a small marketcap of 450m, Corbus could be a real untouched gem in the cannabis industry, compared to its competitors with
4BN+ marketcap.
3) After an agreement with Japananese Kaken Pharmaceutical, Corbus is on the way to receive an additional 173m upon achievement of various milestones
1) Corbus is different from other cannabis stocks as they are designing therapies around marijuana to treat fibrotic diseases. If these therapies work, some analysts put the value of their potential sales at
2BN a year.2) At a small marketcap of 450m, Corbus could be a real untouched gem in the cannabis industry, compared to its competitors with
4BN+ marketcap.3) After an agreement with Japananese Kaken Pharmaceutical, Corbus is on the way to receive an additional 173m upon achievement of various milestones
Thông báo miễn trừ trách nhiệm
Thông tin và ấn phẩm không có nghĩa là và không cấu thành, tài chính, đầu tư, kinh doanh, hoặc các loại lời khuyên hoặc khuyến nghị khác được cung cấp hoặc xác nhận bởi TradingView. Đọc thêm trong Điều khoản sử dụng.